Spero Therapeutics, Inc. (FRA:2HA)
1.818
-0.008 (-0.44%)
At close: Jan 30, 2026
Spero Therapeutics Employees
Spero Therapeutics had 32 employees as of December 31, 2024. The number of employees decreased by 14 or -30.43% compared to the previous year.
Employees
32
Change (1Y)
-14
Growth (1Y)
-30.43%
Revenue / Employee
€1,079,997
Profits / Employee
€1,167,544
Market Cap
103.85M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 32 | -14 | -30.43% |
| Dec 31, 2023 | 46 | 11 | 31.43% |
| Dec 31, 2022 | 35 | -111 | -76.03% |
| Dec 31, 2021 | 146 | 57 | 64.04% |
| Dec 31, 2020 | 89 | 32 | 56.14% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Meta Wolf AG | 939 |
| LEWAG Holding Aktiengesellschaft | 770 |
| Mineralbrunnen Überkingen-Teinach GmbH & Co. KGaA | 385 |
| Netfonds AG | 359 |
| CeoTronics AG | 136 |
| ParTec AG | 62 |
| Samara Asset Group | 12 |
| AGROB Immobilien AG | 5 |